YOU ARE HERE: LAT HomeCollectionsCleveland Clinic

Cleveland Clinic

March 18, 2001 | From Times Wire Reports
An outbreak of Legionnaires' disease at a Ford Motor Co. castings plant claimed its second life late Friday when David Hinderman, 53, died at the Cleveland Clinic. Officials said Hinderman, who worked at the plant, had inhaled Legionnaires' bacteria spread by mist from contaminated water, suspected of emanating from a cooling tower being repaired at the suburban Brook Park facility.
July 9, 1996 | From Times Staff and Wire Reports
Ohio researchers found that taking an over-the-counter zinc lozenge sharply reduced the length of a nasty cold in a study of 100 people. "I was flabbergasted," said Dr. Michael Macknin, chairman of general pediatrics at the Cleveland Clinic Foundation. "I got goose bumps when we broke the code." The researchers found that symptoms disappeared in 4.4 days in people taking zinc gluconate lozenges, compared to 7.6 days in those taking placebos.
June 19, 1991
Dr. Irvine H. Page, 90, one of the first to recognize that high blood pressure and heart attacks are treatable. Through more than two decades of research at the Cleveland Clinic Foundation, Page helped shape understanding and treatment of high blood pressure. The clinic, which he directed, discovered compounds in the body that affect blood pressure. He and his staff proved that these multiple compounds, rather than a single source, were responsible for high blood pressure. In Hyannis Port, Mass.
March 8, 1993
Peter C. Nolan, 52, thoracic and cardiovascular surgeon who performed more than 14,000 open-heart surgeries. Nolan, a native of Philadelphia, was educated at Miami University in Ohio and Temple University Medical School. He began his surgical practice at the Cleveland Clinic. In 1977, he joined the Scripps Memorial Hospital in La Jolla, where he specialized in heart bypass surgery. On Feb. 26 in Solana Beach of colon cancer.
December 4, 2005 | From Times Wire Reports
A cardiologist testifying in Merck & Co.'s federal trial in Houston over Vioxx accused the drug maker of engaging in scientific misconduct, suppressing clinical evidence and stifling medical discourse as it promoted the painkiller. Eric Topol, chairman of the cardiovascular medicine department of the Cleveland Clinic, said Vioxx could cause heart attacks anytime after a patient began taking it, and that its risks were apparent as early as 1999, when the drug was approved.
September 20, 2001 | From Times Wire Reports
A judge in Cleveland has scheduled a hearing on evidence from defense attorneys who say DNA clears a man who has served 13 years in prison on a rape conviction. Michael Green, 35, was convicted of raping a cancer patient at the Cleveland Clinic. The woman died after testifying that Green attacked her. Green was sentenced to 20 to 50 years in prison. Cuyahoga County officials are reviewing the evidence and say they are likely to seek their own DNA testing.
March 20, 1997 | From Associated Press
Figure skating star Scott Hamilton, a four-time world champion and the 1984 Olympic gold medalist, has been told he has testicular cancer, his public relations firm said Wednesday. The diagnosis was made by Eric Klein, a urologist, and Ronald Bukowski, an oncologist, of the Cleveland Clinic Foundation. Hamilton, 38, performed in Peoria, Ill., on Sunday night despite suffering from severe stomach pain during the last several weeks.
July 31, 2000
Rene Favaloro, 77, Argentine surgeon who pioneered coronary bypass surgery. In 1967, Favaloro performed the first bypass operation on a 51-year-old woman at the Cleveland Clinic in Ohio, using a saphenous vein taken from the patient's leg to detour blood around blockages in her heart. The technique is now routinely performed on millions of people each year. Before Favaloro's breakthrough, coronary heart disease had been treated only with medication.
January 31, 1997 | From Newsday
Ever since last summer, when a medical researcher reported that the zinc lozenge Cold-Eeze effectively reduces the severity and duration of colds, there's been a run on the remedy nationwide. Now it turns out the researcher, Dr. Michael Macknin of the Cleveland Clinic Foundation, knew he was onto a good thing: He purchased stock in the lozenge manufacturer, Quigley Corp. of Doylestown, Pa., before his favorable research was published in July.
Los Angeles Times Articles